CIK 0001708527
- Non-accelerated filer
- Smaller reporting company
ELUTIA INC.
Sign in to watch- Ticker
- ELUT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474790334
- Phone
- +1 240-247-1143
- Business address
- 12510 PROSPERITY DRIVE, SUITE 370, SILVER SPRING, MD, 20904
- Former names
- AZIYO BIOLOGICS, INC.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise PRESIDENT AND CEO acquired 44,947 shares (option exercise)
- 4 Open-market buy 10% owner bought 140,000 shares at an average $1.48 ($206,958)
- 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 289 shares at $4.30 ($1,243)
- 4 Option exercise CHIEF FINANCIAL OFFICER acquired 1,287 shares (option exercise)
- 4 Open-market buy 10% owner bought 97,261 shares at an average $4.09 ($398,230)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 3,098 shares at $3.90 ($12,082)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 2,000 shares at $3.65 ($7,300)
- 4 Open-market buy Director bought 735,000 shares at $4.75 ($3,491,250)
- 4 Open-market buy CHIEF FINANCIAL OFFICER bought 28,000 shares at an average $4.51 ($126,400)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 4,798 shares (to pay taxes)
- 4 Shares withheld for taxes GENERAL COUNSEL gave up 1,127 shares (to pay taxes)
Page 6 of 9 · 170 filings